Skip to content
zameds
Loading the molecular structure
C9H8O4180.16 g/mol

2-Acetyloxybenzoic acid

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 2244.

Registration

Applicants
4
Registrations
5

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Adcock ingram limitedCancelledAspirin300 mgB1048Not determinedNone
The Premier Pharmaceutical Co LtdCancelledAspirin300 MG, 500 mgB1455, E0219Not determinedNone
Pharmadyne Healthcare (Pty) LtdAspirin300 mgB1459Not determinedNone
Resmed healthcareAspirin300 mgB1487Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Aspirin 300 MG tablets

EACH TABLET CONTAINS ASPIRIN 300 mg

300 mgTabletsB1048B/2.7/1048CancelledNot determinedNone
Aspirin tablets 300 MG

TABLET ASPIRIN A 300 MG

300 MGTabletsB1455CancelledNot determinedNone
Aspirin 300 MG tablets*

EACH TABLET CONTAINS ASPIRIN 300,0 mg

300 mgTabletsB1459B/2.8/1459RegisteredNot determinedNone
Aspirin 300 MG tablets

EACH TABLET CONTAINS ASPIRIN 300,0 mg

300 mgTabletsB1487B/2.7/1487RegisteredNot determinedNone
Aspirin 500 mg*

EACH TABLET CONTAINS ASPIRIN 500 mg

500 mgE0219E/2.8/219CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S2: Aspirin

    • the treatment of children or adolescents; and
    • the prophylaxis of cardiovascular disease in adults (S0)

    Consolidated Schedules 06 July 2026, lines 1616 to 1620

5 of 7 approved products with this ingredient carry S3 on their leaflet.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles